Chow LQM (2020) Head and neck cancer. N Engl J Med 382(1):60–72

Google Scholar 

Roman BR, Aragones A (2021) Epidemiology and incidence of HPV-related cancers of the head and neck. J Surg Oncol 124(6):920–922

Google Scholar 

Network CGA (2015) Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 517(7536):576–582

Google Scholar 

Zhang Y, Koneva LA, Virani S, Arthur AE, Virani A, Hall PB, Warden CD, Carey TE, Chepeha DB, Prince ME et al (2016) Subtypes of HPV-Positive head and neck cancers are associated with HPV Characteristics, copy number Alterations, PIK3CA Mutation, and pathway signatures. Clin Cancer Res 22(18):4735–4745

Google Scholar 

Leemans CR, Snijders PJF, Brakenhoff RH (2018) The molecular landscape of head and neck cancer. Nat Rev Cancer 18(5):269–282

Google Scholar 

Meng X, Zheng Y, Zhang L, Liu P, Liu Z, He Y (2024) Single-cell analyses reveal the metabolic heterogeneity and plasticity of the tumor microenvironment during head and neck squamous cell carcinoma progression. Cancer Res 84(15):2468–2483

Google Scholar 

Lin YH, Yang YF, Liao JB, Chang TS, Janesha UGS, Shiue YL (2023) Analysis of aldehyde dehydrogenase 2 as a prognostic marker associated with immune cell infiltration and chemotherapy efficacy in head and neck squamous cell carcinoma. J Cancer 14(10):1689–1706

Google Scholar 

Perez-Miller S, Younus H, Vanam R, Chen CH, Mochly-Rosen D, Hurley TD (2010) Alda-1 is an agonist and chemical chaperone for the common human aldehyde dehydrogenase 2 variant. Nat Struct Mol Biol 17(2):159–164

Google Scholar 

Edenberg HJ, Foroud T (2013) Genetics and alcoholism. Nat Rev Gastroenterol Hepatol 10(8):487–494

Google Scholar 

Rodríguez-Zavala JS, Calleja LF, Moreno-Sánchez R, Yoval-Sánchez B (2019) Role of aldehyde dehydrogenases in physiopathological processes. Chem Res Toxicol 32(3):405–420

Google Scholar 

Huang CC, Hsiao JR, Lee WT, Lee YC, Ou CY, Chang CC, Lu YC, Huang JS, Wong TY, Chen KC et al (2017) Investigating the association between alcohol and risk of head and neck cancer in Taiwan. Sci Rep 7(1):9701

Google Scholar 

Harada H, Shinohara S, Takebayashi S, Kikuchi M, Fujiwara K, Michida T, Yamamoto R, Hayashi K, Saida K, Naito Y (2017) Facial flushing after alcohol intake as a predictor for a high risk of synchronous or metachronous cancer of the upper Gastrointestinal tract. Jpn J Clin Oncol 47(12):1123–1128

Google Scholar 

Chang JS, Hsiao JR, Chen CH (2017) ALDH2 polymorphism and alcohol-related cancers in asians: a public health perspective. J Biomed Sci 24(1):19

Google Scholar 

Nene A, Chen CH, Disatnik MH, Cruz L, Mochly-Rosen D (2017) Aldehyde dehydrogenase 2 activation and coevolution of its εPKC-mediated phosphorylation sites. J Biomed Sci 24(1):3

Google Scholar 

Li CF, Chan TC, Pan CT, Vejvisithsakul PP, Lai JC, Chen SY, Hsu YW, Shiao MS, Shiue YL (2021) EMP2 induces cytostasis and apoptosis via the TGFβ/SMAD/SP1 axis and recruitment of P2RX7 in urinary bladder urothelial carcinoma. Cell Oncol (Dordr) 44(5):1133–1150

Google Scholar 

Moore AR, Rosenberg SC, McCormick F, Malek S (2020) RAS-targeted therapies: is the undruggable drugged? Nat Rev Drug Discov 19(8):533–552

Google Scholar 

Rauluseviciute I, Riudavets-Puig R, Blanc-Mathieu R, Castro-Mondragon JA, Ferenc K, Kumar V, Lemma RB, Lucas J, Chèneby J, Baranasic D et al (2024) JASPAR 2024: 20th anniversary of the open-access database of transcription factor binding profiles. Nucleic Acids Res 52(D1):D174–d182

Google Scholar 

Baspinar A, Cukuroglu E, Nussinov R, Keskin O, Gursoy A (2014) PRISM: a web server and repository for prediction of protein-protein interactions and modeling their 3D complexes. Nucleic Acids Res 42(Web Server issue):W285–289

Google Scholar 

Kozakov D, Hall DR, Xia B, Porter KA, Padhorny D, Yueh C, Beglov D, Vajda S (2017) The cluspro web server for protein-protein docking. Nat Protoc 12(2):255–278

Google Scholar 

Liu R, Peng M, Zhang J, Qiu K, Zeng T, Chen L (2024) The ALDH2 gene rs671 polymorphism is associated with cardiometabolic risk factors in East Asian population: an updated meta-analysis. Front Endocrinol (Lausanne) 15:1333595

Google Scholar 

Ma B, Liu Z, Xu H, Liu L, Huang T, Meng L, Wang L, Zhang Y, Li L, Han X (2021) Molecular characterization and clinical relevance of ALDH2 in human cancers. Front Med (Lausanne) 8:832605

Google Scholar 

Tatsukawa H, Hitomi K (2021) Role of transglutaminase 2 in cell death, survival, and fibrosis. Cells. https://doi.org/10.3390/cells10071842

Google Scholar 

Park D, Choi SS, Ha KS (2010) Transglutaminase 2: a multi-functional protein in multiple subcellular compartments. Amino Acids 39(3):619–631

Google Scholar 

Tatsukawa H, Furutani Y, Hitomi K, Kojima S (2016) Transglutaminase 2 has opposing roles in the regulation of cellular functions as well as cell growth and death. Cell Death Dis 7(6):e2244

Google Scholar 

Milakovic T, Tucholski J, McCoy E, Johnson GV (2004) Intracellular localization and activity state of tissue transglutaminase differentially impacts cell death. J Biol Chem 279(10):8715–8722

Google Scholar 

Liu Y, Liu X, Pan C (2024) Advances in factors affecting ALDH2 activity and its mechanisms. Cardiovasc Toxicol. https://doi.org/10.1007/s12012-024-09923-9

Google Scholar 

Mohan HM, Aherne CM, Rogers AC, Baird AW, Winter DC, Murphy EP (2012) Molecular pathways: the role of NR4A orphan nuclear receptors in cancer. Clin Cancer Res 18(12):3223–3228

Google Scholar 

Carpenter MD, Hu Q, Bond AM, Lombroso SI, Czarnecki KS, Lim CJ, Song H, Wimmer ME, Pierce RC, Heller EA (2020) Nr4a1 suppresses cocaine-induced behavior via epigenetic regulation of homeostatic target genes. Nat Commun 11(1):504

Google Scholar 

Pawlak A, Strzadala L, Kalas W (2015) Non-genomic effects of the NR4A1/Nur77/TR3/NGFIB orphan nuclear receptor. Steroids 95:1–6

Google Scholar 

Pekarsky Y, Hallas C, Palamarchuk A, Koval A, Bullrich F, Hirata Y, Bichi R, Letofsky J, Croce CM (2001) Akt phosphorylates and regulates the orphan nuclear receptor Nur77. Proc Natl Acad Sci U S A 98(7):3690–3694

Google Scholar 

Li H, Kolluri SK, Gu J, Dawson MI, Cao X, Hobbs PD, Lin B, Chen G, Lu J, Lin F et al (2000) Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3. Science 289(5482):1159–1164

Google Scholar 

Cheng Z, Völkers M, Din S, Avitabile D, Khan M, Gude N, Mohsin S, Bo T, Truffa S, Alvarez R et al (2011) Mitochondrial translocation of Nur77 mediates cardiomyocyte apoptosis. Eur Heart J 32(17):2179–2188

Google Scholar 

Lin B, Kolluri SK, Lin F, Liu W, Han YH, Cao X, Dawson MI, Reed JC, Zhang XK (2004) Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell 116(4):527–540

Google Scholar 

Kolluri SK, Zhu X, Zhou X, Lin B, Chen Y, Sun K, Tian X, Town J, Cao X, Lin F et al (2008) A short Nur77-derived peptide converts Bcl-2 from a protector to a killer. Cancer Cell 14(4):285–298

Google Scholar 

Chen L, Fan F, Wu L, Zhao Y (2020) The nuclear receptor 4A family members: mediators in human disease and autophagy. Cell Mol Biol Lett 25(1):48

Google Scholar 

Deutsch AJ, Rinner B, Wenzl K, Pichler M, Troppan K, Steinbauer E, Schwarzenbacher D, Reitter S, Feichtinger J, Tierling S et al (2014) NR4A1-mediated apoptosis suppresses lymphomagenesis and is associated with a favorable cancer-specific survival in patients with aggressive B-cell lymphomas. Blood 123(15):2367–2377

Google Scholar 

Downward J (2008) Targeting RAS and PI3K in lung cancer. Nat Med 14(12):1315–1316

Google Scholar 

Kamata H, Tsuchiya Y, Asano T (2010) IκBβ is a positive and negative regulator of NF-κB activity during inflammation. Cell Res 20(11):1178–1180

Google Scholar 

Brown KD (2013) Transglutaminase 2 and NF-κB: an odd couple that shapes breast cancer phenotype. Breast Cancer Res Treat 137(2):329–336

Google Scholar 

Rezatabar S, Karimian A, Rameshknia V, Parsian H, Majidinia M, Kopi TA, Bishayee A, Sadeghinia A, Yousefi M, Monirialamdari M et al (2019) RAS/MAPK signaling functions in oxidative stress, DNA damage response and cancer progression. J Cell Physiol 234(9):14951–14965

Google Scholar 

Chen K, Zhang Y, Qian L, Wang P (2021) Emerging strategies to target RAS signaling in human cancer therapy. J Hematol Oncol 14(1):116

Google Scholar 

Mountzios G, Rampias T, Psyrri A (2014) The mutational spectrum of squamous-cell carcinoma of the head and neck: targetable genetic events and clinical impact. Ann Oncol 25(10):1889–1900

Google Scholar 

Simanshu DK, Nissley DV, McCormick F (2017) RAS proteins and their regulators in human disease. Cell 170(1):17–33

Google Scholar 

Bahar ME, Kim HJ, Kim DR (2023) Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies. Signal Transduct Target Ther 8(1):455

Google Scholar 

Windrich J, Ney GM, Rosenberg PS, Kim J, Zenker M, Stewart DR, Kratz CP (2024) Cancer in multilineage mosaic rasopathies due to pathogenic variants in HRAS or KRAS: a systematic review and meta-analysis. Clin Cancer Res 30(22):5116–5121

Google Scholar 

Liu ZY, Lin XH, Guo HY, Shi X, Zhang DY, Sun JL, Zhang GC, Xu RC, Wang F, Yu XN et al (2024) Multi-Omics profiling identifies aldehyde dehydrogenase 2 as a critical mediator in the crosstalk between Treg-mediated immunosuppression microenvironment and hepatocellular carcinoma. Int J Biol Sci 20(7):2763–2778

Google Scholar 

Marcadier JL, Smith AM, Pohl D, Schwartzentruber J, Al-Dirbashi OY, Majewski J, Ferdinandusse S, Wanders RJ, Bulman DE, Boycott KM et al (2013) Mutations in ALDH6A1 encoding methylmalonate semialdehyde dehydrogenase are associated with dysmyelination and transient methylmalonic aciduria. Orphanet J Rare Dis 8:98

Google Scholar 

Rwere F, White JR, Hell RCR, Yu X, Zeng X, McNeil L, Zhou KN, Angst MS, Chen CH, Mochly-Rosen D et al (2024) Uncovering newly identified aldehyde dehydrogenase 2 genetic variants that lead to acetaldehyde accumulation after an alcohol challenge. J Transl Med 22(1):697

Google Scholar 

Sun J, Ding J, Shen Q, Wang X, Wang M, Huang Y, Zhang X, Zhu H, Zhang F, Wu D et al (2023) Decreased propionyl-CoA metabolism facilitates metabolic reprogramming and promotes hepatocellular carcinoma. J Hepatol 78(3):627–642

Google Scholar 

Li X, Wang N, Wu Y, Liu Y, Wang R (2022) ALDH6A1 weakens the progression of colon cancer via modulating the RAS/RAF/MEK/ERK pathway in cancer cell lines. Gene 842:146757

Google Scholar